Literature DB >> 18677652

Differential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: correlation with E-cadherin.

Anna Batistatou1, Konstantinos Charalabopoulos, Yukihiro Nakanishi, Constantine Vagianos, Setsuo Hirohashi, Niki J Agnantis, Chrissoula D Scopa.   

Abstract

Dysadherin is a novel glycoprotein, with an anti-cell-cell adhesion function. The aim of the present study was to examine the expression of dysadherin in thyroid papillary microcarcinoma (PMC), to associate it with the expression of E-cadherin and to investigate whether there are differences with papillary carcinoma (PC). A statistically significant difference in dysadherin and E-cadherin expression between PC and PMC and a negative correlation between E-cadherin and dysadherin expression regardless of tumor size were noted. Based on these findings it is hypothesized that retained cell-cell adhesion, through maintenance of the E-cadherin adhesion system, in PMC prevents neoplastic cells from dissociating easily from each other and metastasizing. Increased dysadherin expression is possibly one of the post-transcriptional mechanisms responsible for E-cadherin downregulation in thyroid papillary neoplasia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677652     DOI: 10.1007/s12022-008-9035-1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  37 in total

1.  Histopathology of thyroid tumors. An overview.

Authors:  Chrisoula D Scopa
Journal:  Hormones (Athens)       Date:  2004 Apr-Jun       Impact factor: 2.885

2.  E-cadherin gene alterations are rare events in thyroid tumors.

Authors:  P Soares; G Berx; F van Roy; M Sobrinho-Simões
Journal:  Int J Cancer       Date:  1997-01-06       Impact factor: 7.396

3.  Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases.

Authors:  Yukihiro Nakanishi; Shingo Akimoto; Yasuto Sato; Yae Kanai; Michiie Sakamoto; Setsuo Hirohashi
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-12

4.  Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.

Authors:  Mark L C Khoo; Nigel J P Beasley; Shereen Ezzat; Jeremy L Freeman; Sylvia L Asa
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

5.  Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.

Authors:  Aya Nishizawa; Yukihiro Nakanishi; Kimio Yoshimura; Yuko Sasajima; Naoya Yamazaki; Akifumi Yamamoto; Katsumi Hanada; Yae Kanai; Setsuo Hirohashi
Journal:  Cancer       Date:  2005-04-15       Impact factor: 6.860

6.  E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.

Authors:  A S Rocha; P Soares; E Fonseca; J Cameselle-Teijeiro; M C Oliveira; M Sobrinho-Simões
Journal:  Histopathology       Date:  2003-06       Impact factor: 5.087

Review 7.  Dysadherin: a new player in cancer progression.

Authors:  Jeong-Seok Nam; Setsuo Hirohashi; Lalage M Wakefield
Journal:  Cancer Lett       Date:  2007-04-17       Impact factor: 8.679

8.  p130 expression in thyroid neoplasms: its linkage with tumor size and dedifferentiation.

Authors:  Yasuhiro Ito; Hiroshi Yoshida; Takashi Uruno; Keiichi Nakano; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Tamotsu Yokozawa; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  Cancer Lett       Date:  2003-03-20       Impact factor: 8.679

Review 9.  Controversies in papillary microcarcinoma of the thyroid.

Authors:  Monique Piersanti; Shereen Ezzat; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin.

Authors:  A Batistatou; D Peschos; H Tsanou; A Charalabopoulos; Y Nakanishi; S Hirohashi; N J Agnantis; K Charalabopoulos
Journal:  Br J Cancer       Date:  2007-04-17       Impact factor: 7.640

View more
  9 in total

Review 1.  Role of the recently identified dysadherin in E-cadherin adhesion molecule downregulation in head and neck cancer.

Authors:  Alexandros Georgolios; Anna Eleftheriadou; Anna Batistatou; Kostandinos Charalabopoulos
Journal:  Med Oncol       Date:  2011-11-22       Impact factor: 3.064

2.  The O-glycosylated ectodomain of FXYD5 impairs adhesion by disrupting cell-cell trans-dimerization of Na,K-ATPase β1 subunits.

Authors:  Elmira Tokhtaeva; Haying Sun; Nimrod Deiss-Yehiely; Yi Wen; Pritin N Soni; Nieves M Gabrielli; Elizabeth A Marcus; Karen M Ridge; George Sachs; Mónica Vazquez-Levin; Jacob I Sznajder; Olga Vagin; Laura A Dada
Journal:  J Cell Sci       Date:  2016-05-03       Impact factor: 5.285

3.  Increased incidence of papillary thyroid microcarcinoma with decreased tumor size of thyroid cancer.

Authors:  Jen-Der Lin
Journal:  Med Oncol       Date:  2009-06-09       Impact factor: 3.064

4.  E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma.

Authors:  Masanori Nakamura; Naoyoshi Onoda; Satoru Noda; Shinichiro Kashiwagi; Naoki Aomatsu; Kento Kurata; Hidemi Kawajiri; Tsutomu Takashima; Tetsuro Ishikawa; Kosei Hirakawa
Journal:  Mol Clin Oncol       Date:  2013-12-05

5.  Low expression of FXYD5 reverses the cisplatin resistance of epithelial ovarian cancer cells.

Authors:  Ya-Kun Liu; Ya-Jing Jia; Shi-Hao Liu; Hong-Jie Shi; Jing Ma
Journal:  Histol Histopathol       Date:  2021-02-11       Impact factor: 2.303

Review 6.  Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations,Diagnosis, Follow-up, Histopathology and Prognosis.

Authors:  Shiva Dideban; Alireza Abdollahi; Alipasha Meysamie; Shokouh Sedghi; Mona Shahriari
Journal:  Iran J Pathol       Date:  2016

7.  Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes.

Authors:  Samuel Jang; Xiao-Min Yu; Celina Montemayor-Garcia; Kamal Ahmed; Eric Weinlander; Ricardo V Lloyd; Ajitha Dammalapati; David Marshall; James R Prudent; Herbert Chen
Journal:  Oncotarget       Date:  2017-04-11

8.  Expression of E-Cadherin/Beta-Catenin in Epithelial Carcinomas of the Thyroid Gland.

Authors:  Koni Ivanova; Julian Ananiev; Elina Aleksandrova; Maria Magdalena Ignatova; Maya Gulubova
Journal:  Open Access Maced J Med Sci       Date:  2017-03-22

9.  Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma.

Authors:  Lihua Huang; Xuming Wang; Xuan Huang; Huawei Gui; Yan Li; Qiongxia Chen; Dongling Liu; Lijiang Liu
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.